Endothelial dysfunction: Why it belongs in general practice

Consultant

Volumn 40, Issue 8, 2000, Pages 1525-1529

  Nash, David T ^a,b  

^a SUNY Syracuse   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; OXYGEN RADICAL; SELECTIN;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; ECHOGRAPHY; FUNCTION TEST; HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0033861160     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;22(suppl):S1-S4.
3. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999;34:631-638.
4. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
5. Panza JA Endothelial dysfunction in essential hypertension. Clin Cardiol. 1997;20(suppl):II-26-II-33.
6. Panza JA Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145-1151.
7. Mancini GBJ, Henry GC, Macaya C, et al Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation. 1996;94:258-265.
8. Creager MA, Selwyn A When "normal" cholesterol levels injure the epithelium. Circulation. 1997; 96:3255-3257.
9. Steinberg HO, Bayazeed B, Hook G, et al Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation. 1997;96:3287-3293.
10. Vogel RA Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350-354.
11. Lundman P, Eriksson M, Schenck-Guslafeson K, et al. Transient triglyceridemia decreases vascular reactivity in young healthy men without risk. Circulation. 1997;96:3266-3268.
12. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 1993;87(suppl):V67-V76.
13. Drexler H. Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition. Br Heart J. 1994;72(suppl):S11-S14.
14. Hasdai D, Gibbons RJ, Holmes DR Jr, et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96: 3390-3395.
15. Cannon RO III. Does coronary endothelial dysfunction cause myocardial ischemia in the absence of obstructive coronary artery disease? Circulation. 1997;96:3251-3254.
16. Celermajer DS, Sorensen KE, Georgakopoulos D, et al: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149-2155.
17. Böger RH, Bode-Böger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Circulation. 1998;98: 1842-1847.
18. Barron MK, Lake RS, Buda AJ, Tenaglia AN. Intimai hyperplasia after balloon injury is attenuated by blocking selectins. Circulation. 1997;96:3587-3592.
19. Lefer AM. Selectins: vital vasculotropic vectors involved in vascular remodeling. Circulation. 1997;96: 3258-3260.
20. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062-1071.
21. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96: 3264-3265.
22. 2 production in the pig coronary artery Circulation. 1997;96:3593-3601.
23. Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 1997;96:2542-2544.
24. Celermajer DS, Sorensen KE, Ryalls M, et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 1993;22:854-858.
25. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits from increasing folic acid intakes. JAMA. 1995;274:1049-1057.
26. Clarkson P, Celermajer DS, Powe AJ, et al. Endothelium-dependent dilation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation. 1997;96:3378-3383.
27. Kaprio J, Norio R, Pesonen E, Sarna S. Intimai thickening of the coronary arteries in infants in relation to family history of coronary artery disease, Circulation. 1993;87:1960-1968.
28. Henrion D, Benessiano J, Philip I, et al. The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro. J Am Coll Cardiol. 1999;34:830-836.
29. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986; 315:1045-1051.